S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
Log in

NASDAQ:DCPHDeciphera Pharmaceuticals Price Target & Analyst Ratings

$45.27
-1.98 (-4.19 %)
(As of 08/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$44.68
Now: $45.27
$47.36
50-Day Range
$46.07
MA: $51.80
$62.17
52-Week Range
$31.37
Now: $45.27
$71.11
Volume248,623 shs
Average Volume543,906 shs
Market Capitalization$2.55 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.98

Analyst Ratings

Deciphera Pharmaceuticals (NASDAQ:DCPH) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
15 Wall Street analysts have issued ratings and price targets for Deciphera Pharmaceuticals in the last 12 months. Their average twelve-month price target is $70.00, suggesting that the stock has a possible upside of 54.63%. The high price target for DCPH is $91.00 and the low price target for DCPH is $49.00. There are currently 3 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.802.812.812.92
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $70.00$68.31$66.56$65.00
Price Target Upside: 54.63% upside25.94% upside21.04% upside2.55% downside

Deciphera Pharmaceuticals (NASDAQ:DCPH) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Deciphera Pharmaceuticals (NASDAQ:DCPH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/5/2020SVB LeerinkLower Price TargetMarket Perform$55.00 ➝ $54.00Low
6/12/2020GuggenheimReiterated RatingBuy$70.00High
5/18/2020SunTrust BanksBoost Price TargetBuy$82.00 ➝ $91.00Medium
5/18/2020BarclaysReiterated RatingBuy$80.00 ➝ $85.00Medium
5/7/2020Nomura InstinetDowngradeBuy ➝ Neutral$84.00 ➝ $60.00Low
5/6/2020JPMorgan Chase & Co.Lower Price TargetOverweight$50.00 ➝ $49.00High
5/6/2020HC WainwrightBoost Price TargetBuy$60.00 ➝ $80.00High
1/22/2020Piper SandlerReiterated RatingBuy$75.00Low
1/21/2020Nomura SecuritiesBoost Price TargetBuy$57.00 ➝ $84.00Low
1/15/2020JMP SecuritiesReiterated RatingBuy$70.00Low
12/20/2019Piper Jaffray CompaniesBoost Price TargetOverweight$55.00 ➝ $75.00Low
12/20/2019Jefferies Financial GroupBoost Price TargetBuy$53.00 ➝ $77.00Medium
8/14/2019Cantor FitzgeraldBoost Price TargetOverweight$43.00 ➝ $55.00High
8/14/2019Canaccord GenuityReiterated RatingBuy ➝ Buy$50.00 ➝ $65.00Medium
7/18/2019Deutsche BankInitiated CoverageBuy ➝ Buy$42.00Low
1/1/2019B. RileyDowngradeBuy ➝ NeutralHigh
8/29/2018Raymond JamesInitiated CoverageOutperform ➝ Outperform$47.00Medium
(Data available from 8/14/2018 forward)
This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.